These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4689164)

  • 1. [Plasmatic haptoglobin in chronic coronary disease and in myocardial infarct. Physiopathological significance. Diagnostic importance].
    Păunescu-Podeanu A; Bolocan T; Grecu O
    Med Interna (Bucur); 1973 Jan; 25(1):17-24. PubMed ID: 4689164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of behaviour of fibrinogen and of some glycoproteins in arteriosclerotic clinical situations (author's transl)].
    Sarno A; La Bruzzo S; Catania A; Francavilla G; Romano A; Caimi G
    G Ital Cardiol; 1980; 10(1):65-71. PubMed ID: 7461310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum haptoglobin level in atherosclerosis.
    Székely J; Simon A; Horváth E
    Acta Med Acad Sci Hung; 1971; 28(1):19-26. PubMed ID: 5133496
    [No Abstract]   [Full Text] [Related]  

  • 4. [The haptoglobin level of blood in arteriosclerosis].
    Székely J; Simon A; Horváth E
    Orv Hetil; 1970 Jan; 111(1):29-32. PubMed ID: 5415259
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombogenesis in atherosclerosis of the coronary arteries].
    Petrova TP; Pavlishchuk SA
    Ter Arkh; 1968 Jan; 40(1):41-5. PubMed ID: 5747054
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of serum haptoglobin concentration in the acute phase of myocardial infarct by means of Mancini's simple radial immunodiffusion test].
    Boguschewski KD; Mann D; Röhr A; Steinbrück U
    Z Gesamte Inn Med; 1981 Dec; 36(23):933-6. PubMed ID: 6805142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
    Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
    Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Certain indicators of lipid metabolism in erythrocytic membranes and plasma in coronary arteriosclerosis and myocardial infarct].
    Borinskiĭ IuN; Sidorenkov MI
    Sov Med; 1975 Oct; (10):143-5. PubMed ID: 1209320
    [No Abstract]   [Full Text] [Related]  

  • 9. [Semeiotic value of haptoglobin and seromucoid determinations in coronary disease].
    Jayle MF; Choubrac P; Drosdowsky MA; Jacot P
    Presse Med (1893); 1968 Oct; 76(38):1805-8. PubMed ID: 5737543
    [No Abstract]   [Full Text] [Related]  

  • 10. [Haptoglobin and myocardial infarct].
    Stabilini R; Vergani C; Agostoni A
    Atti Soc Ital Cardiol; 1968; 2():280-1. PubMed ID: 5743858
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes of fibrinogenemia in myocardial infarct and coronary insufficiency].
    DJORDJEVIC BS; STRASER T
    Srp Arh Celok Lek; 1961 Feb; 89():127-30. PubMed ID: 13723181
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative haptoglobin and properdin determinations in patients with myocardial infarct].
    Karl M; Feissman G
    Z Gesamte Inn Med; 1967 Nov; 22(22):720-4. PubMed ID: 5623740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipid peroxidation of the blood neutrophils of patients with an ischemic insult and myocardial infarct and of their relatives].
    Davidenkova EF; Shafran MG; Grigor'eva VV; Kolosova NN; Liberman IS
    Klin Med (Mosk); 1984 Nov; 62(11):79-81. PubMed ID: 6521384
    [No Abstract]   [Full Text] [Related]  

  • 14. [Haptoglobin phenotype distribution in patients at high risk of developing myocardial infarct].
    Gogishvili AV; Kavtaradze VG; Mamaladze GT; Arutiunova MS; Takadze GSh
    Kardiologiia; 1985 Feb; 25(2):55-8. PubMed ID: 3990081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood kinin system in pathogenesis and clinic of ischaemic heart disease.
    Dzizinskii AA; Kuimov AD
    Cor Vasa; 1972; 14(1):9-15. PubMed ID: 5022134
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
    Dordević BS; Bosnjaković V; Baklaja-Jevremović R; Nastić D
    Acta Med Iugosl; 1970; 24(1):7-19. PubMed ID: 5201592
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood haptoglobin in patients with myocardial diseases].
    Chernikhovskaia LS; Fedorov VV; Stepanov BP
    Lab Delo; 1985; (5):274-6. PubMed ID: 2409331
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
    Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
    Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New differential diagnostic possibilities in the diagnosis of myocardial infarct and coronary sclerosis].
    Balassa A; Berzy I; Porgányi M; Révai S; Simon J
    Z Allgemeinmed; 1971 Apr; 47(11):596-8. PubMed ID: 5553248
    [No Abstract]   [Full Text] [Related]  

  • 20. Levels of soluble fibrin monomer complexes in the course of myocardial infarction.
    Nowak A; Lipiński B; Drzewiecki J
    Br Heart J; 1972 Jun; 34(6):593-6. PubMed ID: 5040258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.